Truist Securities Maintains Buy on BKV, Raises Price Target to $34

Truist Securities analyst Gabe Daoud has maintained a Buy rating on BKV (NYSE: BKV) and has raised the price target from $33 to $34. This adjustment reflects a positive outlook on the company's performance.